Home › Bronchiolitis Obliterans Syndrome
Bronchiolitis Obliterans Syndrome clinical trials recruiting in the U.S.
43 studies for Bronchiolitis Obliterans Syndrome are recruiting participants at sites across the United States.
Cities with the most studies
- Boston, MA13 studies
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Tampa, FL6 studies
- Philadelphia, PA6 studies
- Columbus, OH6 studies
- Baldwin Park, CA6 studies
- Washington, DC6 studies
- Durham, NC6 studies
- Pittsburgh, PA5 studies
- San Francisco, CA5 studies
- Portland, OR5 studies
- Chicago, IL5 studies
- Orlando, FL4 studies
- Charlotte, NC4 studies
- Nashville, TN4 studies
- Ann Arbor, MI4 studies
- Richmond, VA4 studies
- Salt Lake City, UT4 studies
- Detroit, MI4 studies
- St. Louis, MO4 studies
- Cincinnati, OH3 studies
- Denver, CO3 studies
- San Antonio, TX3 studies
- Austin, TX3 studies
- Mountain View, CA3 studies
- Cleveland, OH3 studies
- Charleston, SC3 studies
- Edison, NJ3 studies
- Kansas City, KS3 studies
- Birmingham, AL3 studies
- Dallas, TX3 studies
By state
- Alabama3 studies
- Arizona3 studies
- California16 studies
- Colorado4 studies
- District of Columbia3 studies
- Florida14 studies
- Georgia11 studies
- Illinois6 studies
- Kansas5 studies
- Maryland5 studies
- Massachusetts14 studies
- Michigan7 studies
- Missouri4 studies
- New Jersey4 studies
- New York11 studies
- North Carolina7 studies
- Ohio9 studies
- Oregon6 studies
- Pennsylvania11 studies
- South Carolina3 studies
- Tennessee6 studies
- Texas12 studies
- Utah4 studies
- Virginia4 studies
- Washington11 studies
Recently updated studies
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07011810A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 22, 2026 · NCT07116031Evaluation of Patients With Immune Function Abnormalities
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Sep 22, 2026 · NCT00128973An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Sep 21, 2026 · NCT07395232Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 120 · All sexes · Updated Sep 18, 2026 · NCT05327023Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05996627A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Sep 15, 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774Repetitive Transcranial Magnetic Stimulation, a Form of Non-invasive Brain Stimulation, as a Possible Treatment for Post-stroke Fatigue
RecruitingPhase 2
Ages 34 to 80 · All sexes · Updated Sep 14, 2026 · NCT05584124Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RecruitingHealthy volunteers welcome
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT02592291Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 2, 2026 · NCT07354074Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07127926Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
Recruiting
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07535008Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06660355A Long-term Extension Study of PCI-32765 (Ibrutinib)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT01804686NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Recruiting
Ages 18 to 75 · All sexes · Updated Jul 24, 2026 · NCT06810622Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
RecruitingPhase 1
Ages 2 and older · All sexes · Updated Jul 23, 2026 · NCT06991361Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jul 15, 2026 · NCT05951777UTSW NORC Pilot Spinal Cord Injury Dietary Program
Recruiting
Ages 18 to 65 · All sexes · Updated Jul 15, 2026 · NCT06924177Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
RecruitingObservational study
Ages 7 and older · All sexes · Updated Jul 14, 2026 · NCT07434869Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jun 22, 2026 · NCT06663722A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain
Recruiting
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT07214844A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 85 · All sexes · Updated Jun 11, 2026 · NCT04959175From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.